| 张慧芹刘泽洲续畅李健牛建昭郝钰△.小檗碱与罗格列酮干预高脂饮食诱导大鼠非酒精性脂肪性肝炎
的比较观察*[J].,2014,14(20):3806-3809 |
| 小檗碱与罗格列酮干预高脂饮食诱导大鼠非酒精性脂肪性肝炎
的比较观察* |
| Comparison of the Efficacy between Berberine and Rosiglitazonein Non-alcoholic Steatohepatitis Rats Induced by High Fat Fiet* |
| |
| DOI： |
| 中文关键词: 小檗碱 罗格列酮 非酒精性脂肪性肝炎 大鼠 |
| 英文关键词: Berberine Rosiglitazone Non-alcoholic steatohepatitis Rat |
| 基金项目:国家自然科学基金面上项目（30873268）；高等学校学科创新引智计划资助项目（B07007） |
|
| 摘要点击次数: 486 |
| 全文下载次数: 745 |
| 中文摘要: |
| 摘要目的：比较中药单体化合物小檗碱和噻唑烷二酮类药物罗格列酮对高脂饲料诱导大鼠非酒精性脂肪性肝炎（NASH）的干预
作用，探讨小檗碱成为天然胰岛素增敏剂的可能性。方法：雄性SD 大鼠40 只，随机分为4 组，采用连续饲喂高脂饲料的方法诱导
大鼠NASH，以预防给药的方式灌胃给予小檗碱（100 mg/kg 体重）和罗格列酮（20 mg/kg 体重），持续8 周后取材。采用生化分析
的方法检测大鼠血清胆固醇（CHO）、甘油三酯（TG）、高密度脂蛋白（HDL）、低密度脂蛋白（LDL）、空腹血糖（FPG）及空腹胰岛素
（FINS）并计算胰岛素抵抗指数（HOMA-IR）。采用常规石蜡切片HE染色、冰冻切片油红O 染色评估NASH的病理程度，用常规
免疫组织化学方法检测了肝组织中PPAR-γ的表达。结果：小檗碱和罗格列酮均能较好的干预高脂饲料诱导大鼠NASH的病理
过程。此外，二者均能改善大鼠胰岛素抵抗状态、上调肝组织中PPAR-γ的水平。结论：小檗碱和罗格列酮均能较好的改善高脂饲
料诱导的大鼠NASH 病理过程，二者共同的药理机制是改善胰岛素抵抗状态和上调肝组织中PPAR-酌的表达。该实验结果提示：
小檗碱有望开发为具有胰岛素增敏作用的天然药物。 |
| 英文摘要: |
| ABSTRACT Objective:The study was to compare the efficacy of berberine and rosiglitazone in the treatment of non-alcoholic
steatohepatitis (NASH) rats induced by high fat diet, so as to investigate the possibility of substituting rosiglitazone. Methods:40 Male
SD rats were randomly divided into 4 groups (10 rats per group), i.e. the normal group (fed with normal diet), the NASH model group
(fed with high fat diet), Rosiglitazone treatment group (20 mg/Kg body weight) and berberine treatment group (100 mg/Kg body weight).
Drugs were adopted in the preventive intervention method for 8 weeks. The hepatic histopathology method was adopted to evaluate the
drug therapeutic effect. The serum levels of cholesterol (CHO), triglyceride (TG), high density lipoprotein (HDL), low density lipoprotein
(LDL), fasting plasma glucose (FPG), and fasting insulin (FINS) were examined with biochemical method. And then, HOMA-IR was
calculated to show insulin resistance. And PPAR-γexpression on hepatic tissue was detected by immunohistochemistry method.
Results:The results showed berberine and rosiglitazone could improve the degree of hepatic histopathology. Furthermore, both drugs can improve
insulin resistance, and up-regulate the level of PPAR-γon hepatic tissue. Conclusion:Berberine and rosiglitazone could alleviate the
pathological process in high fat diet induced NASH model possibly through improving insulin resistance, up regulating PPAR-γ
expression. The results suggest that berberine is expected to be developed into a natural drug with insulin sensitization effect. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
